FDA Approved: LENALIDOMIDE — Original Application (Devatis Inc.)

View source ↗

Summary

FDA approved a generic lenalidomide under the original application from Devatis Inc., enabling market access for this established cancer therapy. The approval c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes with 5q Deletion
• Small Lymphocytic Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

ORIG AP for LENALIDOMIDE (LENALIDOMIDE)